MedPath

Kwath in gout (increased uric acid)

Phase 2
Conditions
Health Condition 1: M200- Deformity of finger(s)
Registration Number
CTRI/2020/04/024821
Lead Sponsor
Archana arya
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Other
Sex
Not specified
Target Recruitment
36
Inclusion Criteria

1. Patient having symptoms of Vatarakta.

2. Patient willing to participate in the trial and with informed consent

Exclusion Criteria

1.Pateints with age of <30 years and >60 years

2.Known case of Septic arthritis, osteoarthritis, rheumatoid arthritis.

3.Known case of Severe systemic multi organ failure

4.Patient with secondary hyperuricemia (i.e., patient on ATT, chemotherapy)

5.Patient with uncontrolled diabetes.

6.Patients with renal impairment.

7.Patients with autoimmune disease (i.e., patient of RA, psoriasis)

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in all symptoms of goutTimepoint: 6 weeks
Secondary Outcome Measures
NameTimeMethod
Hb%, TLC, DLC, ESR, serum uric acid, blood sugar, serum creatinin, blood urea, urine (routine and microscopic)Timepoint: 6 weeks
© Copyright 2025. All Rights Reserved by MedPath